Abstract:Background & Aims: Although CD8(+)T cell exhaustion hampers viral control during chronic HBV infection, the pool of CD8(+)T cells is phenotypically and functionally heterogeneous. Therefore, a specific subpopulation of CD8(+)T cells should be further investigated. This study aims to dissect a subset of CD8(+)T cells expressing C-X-C motif chemokine receptor 5 (CXCR5) in chronic HBV infection. Methods: The frequency of CXCR5(+)CD8(+)T cells and the levels of C-X-C motif chemokine ligand 13 (CXCL13), a chemokine of CXCR5, were measured in patients with chronic HBV infection. C57BL/6, interleukin (IL)-21 receptor- or B cell-deficient mice were hydrodynamically injected with pAAV-HBV1.2 plasmids. Phenotype and functions of peripheral and intrahepatic CXCR5(+) and CXCR5(-)CD8(+)T cells were assessed. Results: CXCR5(+)CD8(+)T cells were partially exhausted but possessed a stronger antiviral ability than the CXCR5(-) subset in patients with chronic HBV infection; moreover, CXCR5(+)CD8(+)T cells were associated with a favorable treatment response in patients with chronic hepatitis B (CHB). High levels of CXCL13 from patients with CHB facilitated the recruitment of intrahepatic CXCR5(+)CD8(+)T cells, and this subpopulation produced high levels of HBV-specific interferon (IFN)-gamma and IL-21. Notably, PD1 (programmed death 1) blockade and exogenous IL-21 enhanced the production of IFN-gamma. More strikingly, mice injected with CXCR5(+)CD8(+)T cells showed remarkably decreased expression of HBsAg. Additionally, an impaired production of HBV-specific IFN-gamma from intrahepatic CXCR5(+)CD8(+)T cells was observed in IL-21 receptor- or B cell-deficient mice. Conclusion: CXCL13 promotes the recruitment of CXCR5(+)CD8(+)T cells to the liver, and this subpopulation improves viral control in chronic HBV infection. The identification of this unique sub- population may contribute to a better understanding of CD8(+)T cell functions and provide a potential immunotherapeutic target in chronic HBV infection. Lay summary: Exhaustion of CD8(+)T cells is an important factor in the development of chronic hepatitis B virus (HBV) infection. CD8(+)T cells expressing the receptor CXCR5 are partially exhausted, but have potent antiviral activity, as they produce high levels of HBV-specific cytokines in chronic HBV infection. Increased expression of CXCL13 within the liver facilitates the recruitment of CXCR5(+)CD8(+)T cells and establishes effective immune control of HBV infection. (C) 2019 European Association for the Study of the Liver. Published by Elsevier B.V.

295 ALTERATIONS IN CD4+CXCR5+ TFH CELLS IN DIFFERENT CLINICAL STAGES OF CHRONIC HBV INFECTION

Decreased CD122 on CD56dim NK associated with its impairment in asymptomatic chronic HBV carriers with high levels of HBV DNA, HBsAg and HBeAg

Restored Circulating Invariant NKT Cells Are Associated with Viral Control in Patients with Chronic Hepatitis B.

High Frequencies of CD158b+ NK Cells Are Associated with Persistent Hepatitis C Virus Infections

Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.

CXCL13-mediated Recruitment of Intrahepatic CXCR5+CD8+T Cells Favors Viral Control in Chronic HBV Infection.

Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control During Antiviral Therapy

Chronic HCV Infection Affects the NK Cell Phenotype in the Blood More than in the Liver

Expansion of Functionally Skewed CD56-Negative NK Cells in Chronic Hepatitis C Virus Infection: Correlation with Outcome of Pegylated IFN-α and Ribavirin Treatment

Changes in NK cells and regulatory T cells among patients with refractory chronic hepatitis C during antiviral treatment

Expressions of natural killer-associated receptors on cytotoxic T lymphocyte from peripheral blood of patients with chronic hepatitis B

Expansion of dysfunctional CD56-CD16+ NK cells in chronic hepatitis B patients

The frequency,phenotypes and invtiro cytotoxic effects of icrculating CD 56+T cells in the patients with chornic HCV infection

Recovery of Circulating CD56dim NK Cells and the Balance of Th17/Treg after Nucleoside Analog Therapy in Patients with Chronic Hepatitis B and Low Levels of HBsAg

Association of NK Cells with the Severity of Fibrosis in Patients with Chronic Hepatitis C

Antiviral Treatment Alters the Frequency of Activating and Inhibitory Receptor-Expressing Natural Killer Cells in Chronic Hepatitis B Virus Infected Patients

Elevated Hepatic CD1d Levels Coincide with Invariant NKT Cell Defects in Chronic Hepatitis B Virus Infection

Characteristics of peripheral blood natural killer cell subsets in patients with chronic hepatitis B during the early phase of antiviral treatment

Altered Immune Profiles Of Natural Killer Cells In Chronic Hepatitis B Patients: A Systematic Review And Meta-Analysis

Analysis of NK Cells and Receptors in Peripheral Blood of Patients with HBV Related Acute-on-chronic Liver Failure in Different Phases

Cytokine profiles and virological markers highlight distinctive immune statuses, and effectivenesses and limitations of NAs across different courses of chronic HBV infection